Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 4339 for “"Antagonist"”.

  1. EVALUATION OF HUMAN PROLACTIN, ITS ANTAGONIST, AND ANTAGONIST-BASED FUSION PROTEINS AS CHEMOPREVENTATIVE AND THERAPEUTIC AGENTS

    … Previously, fusion proteins composed of a PRLR antagonist (G129R) and anti-tumor domains were developed; these included fusions with an angiogenesis inhibitor (Endostatin), an immune system modulator (interleukin-2), and a cytotoxin (PE38KDEL). The rationale was that each fusion protein would …

    clemson Repository record for EVALUATION OF HUMAN PROLACTIN, ITS ANTAGONIST, AND ANTAGONIST-BASED FUSION PROTEINS AS CHEMOPREVENTATIVE AND THERAPEUTIC AGENTS (opens in a new tab)

  2. Preclinical Pharmacology of the MDM2 Antagonist Nutlin-3a

    Nutlin-3a is an MDM2-p53 interaction antagonist that is under investigation in preclinical models for a variety of pediatric malignancies, including neuroblastoma, retinoblastoma, leukemia, and rhabdomyosarcoma. In the current research, we conducted preclinical pharmacology studies of nutlin-3a to …

    tenn-hsc Repository record for Preclinical Pharmacology of the MDM2 Antagonist Nutlin-3a (opens in a new tab)

  3. SYNTHESIS OF SELECTIVE C-TYPE LECTIN ANTAGONIST GLYCOMIMETICS

    In this thesis we have tackled the problem of identifying high-affinity, selective CLR ligands with two different approaches: in the first approach, we synthesized a diversity library and screened it in microarray format against a group of human CLRs; in the second approach we proceeded to the …

    milano Repository record for SYNTHESIS OF SELECTIVE C-TYPE LECTIN ANTAGONIST GLYCOMIMETICS (opens in a new tab)

  4. IAP antagonist Grim mediates cell death through divergent pathways

    … or enhanced by the accumulation of “IAP antagonists”, which promote cell death by utilizing their N-terminal IAP binding motifs (IBMs) to interact with IAPs, to displace caspases from IAP-binding, and to promote IAPs autoubiquitination. Herein, we demonstrate that a Drosophila IAP …

    texas Repository record for IAP antagonist Grim mediates cell death through divergent pathways (opens in a new tab)

  5. Characteristics of iodinated beta-adrenoceptor antagonist ligands in brain.

    … interactions of radiolabelled beta-adrenoceptor antagonists with membranes from cerebral tissue of the rat using ligand binding methods. <br></br><br></br> Using tritiated ligands and displacement of the binding with selective beta-adrenoceptor agents (distinguishing between <i>β</i><sub>1</sub>- …

    the-open-u Download PDF for Characteristics of iodinated beta-adrenoceptor antagonist ligands in brain. (opens in a new tab)

  6. Design, Synthesis and Biological Evaluation of Novel Cannabinoid Antagonist

    … diaryl group revealed in the prototypical antagonist/inverse agonist SR141716 (Rimonabant) that was pre­sumed to interact with a unique region in the CB1 receptors. Based on our prelimi­nary results we identified a novel series of 1,2,3-triazole ester and keto deriva­tives as lead compounds …

    uno Repository record for Design, Synthesis and Biological Evaluation of Novel Cannabinoid Antagonist (opens in a new tab)

  7. Molecular evolution of a C5aR antagonist against inflammatory disease

    New anti-inflammatory drugs with fewer adverse effects than existing drugs may prove to be useful in the treatment of several inflammatory disorders. A critical step in acute inflammation is the infiltration of neutrophils into tissues. Therefore, molecules that target and inhibit this early …

    lund Repository record for Molecular evolution of a C5aR antagonist against inflammatory disease (opens in a new tab) Download PDF for Molecular evolution of a C5aR antagonist against inflammatory disease (opens in a new tab)

  8. Wear behavior of zirconia substrates against different antagonist materials

    … distinct surface roughness against different antagonist materials.<br><br>Method: Hemisphere-shaped specimens (diameter of 5mm) constructed from different materials (VM9, Vintage ZR, IPS e.max Press and human enamel) were used as antagonists against plates of two zirconia materials (P-NANOZR, …

    freiburg-diss Repository record for Wear behavior of zirconia substrates against different antagonist materials (opens in a new tab)

  9. Cyclization and Derivatization of the Potasium Channel Antagonist Tertiapin

    The potent potassium channel antagonist tertiapin-Q was used in order to expand the application of data previously published by Clark et al. and also to further examine the usefulness of a newly published peptide backbone cyclization technique. This peptide was also used in order to investigate the …

    hawaii Repository record for Cyclization and Derivatization of the Potasium Channel Antagonist Tertiapin (opens in a new tab)

  10. MMTV encodes a protein antagonist of multiple Apobec family members

    … MMTV infection [179], yet no known MMTV-encoded antagonist of mA3 has been identified. MMTV requires replication through B and T lymphocytes [33, 34, 37], both of which express Apobec family proteins, prior to mammary gland infection and tumorigenesis [93, 97]. Experiments were performed to …

    texas Repository record for MMTV encodes a protein antagonist of multiple Apobec family members (opens in a new tab)

  11. Deactivation of the LPS antagonist eritoran by HDL-associated apolipoproteins

    … a synthetic lipid A analogue that is a powerful antagonist of LPS, however it undergoes a time-dependent deactivation after administration as a consequence of binding to high-density lipoproteins (HDL). At present, there remains much uncertainty surrounding the site of eritoran association with …

    ubc Repository record for Deactivation of the LPS antagonist eritoran by HDL-associated apolipoproteins (opens in a new tab) Download PDF for Deactivation of the LPS antagonist eritoran by HDL-associated apolipoproteins (opens in a new tab)

  12. Identification and in vivo Characterization of a Potential TAAR1 Antagonist

    … selective agonists for TAAR1, only one TAAR1 antagonist has been described thus far. We used an in silico screen on a TAAR1 homology model and identified several novel agonists and potential antagonists for TAAR1. One of the identified antagonists (compound 22) was predicted to have favourable …

    toronto-retro Repository record for Identification and in vivo Characterization of a Potential TAAR1 Antagonist (opens in a new tab)

Page 1 of 217